Bacillus Calmette-Guerin (BCG) therapy has been proven to be effective treatment for superficial bladder carcinoma with complications that are usually minor and self limited. Although rare, granulomatous hepatitis can develop, and it is important to recognize it and treat it promptly. The hepatitis which occurs appears to be the result of a hypersensitivity reaction to antigens present in the B...

Received March 11, 2011, Revised August 29, 2011, Accepted for publication August 30, 2011 Corresponding author: Chi Yeon Kim, M.D., Ph.D., Department of Dermatology, Gyeongsang National University Hospital, 79 Gangnam-ro, Jinju 660-702, Korea. Tel: 82-55-750-8184, Fax: 82-55-7588106, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons...

Intracavitary instillation of Tokyo 172 strain Bacillas Calmette-Guerin was performed on 39 patients with superficial bladder cancer after contact Nd:YAG laser irradiation for tumors. The BCG group received intravesical instillation of 80 mg BCG at two week intervals for 6 months. Recurrence occurred in 7 of the 39 patients. In the 7 recurrent cases instillation of BCG had been discontinued aft...

Received October 2006 Accepted March 2007 INTRODUCTION Intravesical instillation of bacillus Calmette-Guerin (BCG) is a known treatment method in superficial bladder cancers after transurethral resection of the bladder tumor (TURBT).(1) Moreover, its polysaccharide nucleotide is used in the treatment of asthma.(2) However, the most familiar usage of the BCG to the public is vaccination against ...

The effect of preimmunization with Bacillus Calmette-Guerin cell walls (BCGcw) on tumor growth was studied with the use of transplantable Morris Hepatoma 3924a in inbred ACl rats. There was an increase in tumor incidence, an increase in the i.m. tumor growth rate, and an increase in the average i.m. tumor mass in animals that were preimmunized with BCGcw. The BCGcw-induced enhancement in tumor ...

Approximately 70% of bladder transitional epithelium cell carcinomas are non-invasive muscular bladder cancers, and for the treatment and prevention of recurrence of this type of cancer, Bacillus Calmette-Guerin (BCG) is applied prophylactically. This practice is generally considered reliable and rarely causes systemic complications. We present here a case in which the patient underwent transur...

Henoch Schönlein purpura (HSP), also known as IgA vasculitis (IgAV), is a systemic small-vessel vasculitis that predominantly affects adolescents and is rare in adults. In many cases, the onset of HSP has been causally linked to an infectious disease. We encountered a case of HSP with severe renal involvement diagnosed by renal biopsy following bacillus Calmette-Guerin (BCG) therapy for bladder...

Infections and/or immune-mediated reactions may occur after intravesical instillation of bacillus Calmette-Guérin for the treatment of bladder carcinoma. We report herein a cryoglobulinemia vasculitis occurring after intravesical BCG instillation for a superficial papillary transitional cell bladder carcinoma. The patient, an 80-year-old man, presented peripheral ischemia 10 days after the seco...

RATIONALE Recently, drug-related myasthenia gravis (MG) has received attention, because the number of reported cases involving MG associated with immune checkpoint inhibitors, a new immunotherapy, is increasing. We present a case involving the new onset of MG, in which the symptoms started shortly after intravesical Bacillus Calmette-Guerin (BCG) for bladder cancer. PATIENT CONCERNS A 69-year...